In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii
-
Published:2023-06-01
Issue:1
Volume:10
Page:11-17
-
ISSN:1727-3706
-
Container-title:Vaccine Research
-
language:en
-
Short-container-title:vacres
Author:
Sabzi SamiraORCID,
Badmasti FarzadORCID,
Noori Goodarzi NarjesORCID,
Habibi MehriORCID,
Shahbazi ShahlaORCID,
Asadi Karam Mohammd RezaORCID,
Farokhi MehdiORCID
Publisher
Apex Publishing
Reference49 articles.
1. 1. Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert opinion on pharmacotherapy. 2010;11(5):779-88.
2. 2. Tiku V. Acinetobacter baumannii: Virulence strategies and host defense mechanisms. DNA and Cell Biology. 2022;41(1):43-8.
3. 3. Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. International journal of antimicrobial agents. 2011;37(2):102-9.
4. 4. Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T, Blatt NL. World Health Organization report: current crisis of antibiotic resistance. BioNanoScience. 2019;9:778-88.
5. 5. Badmasti F, Ajdary S, Bouzari S, Fooladi AAI, Shahcheraghi F, Siadat SD. Immunological evaluation of OMV (PagL)+ Bap (1-487aa) and AbOmpA (8-346aa)+ Bap (1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection. Molecular immunology. 2015;67(2):552-8.